ORCID: https://orcid.org/0009-0008-1190-9435; Uibel, Paula; Berberich, Cornelius; Schaller-Nagengast, Jonas; Mitrevski, Vasil; Hutter, Leo; Tumani, Hayrettin
ORCID: https://orcid.org/0000-0002-1647-6201; Havla, Joachim
ORCID: https://orcid.org/0000-0002-4386-1340; Gasperi, Christiane
ORCID: https://orcid.org/0000-0002-0524-6005; Mühlau, Mark
ORCID: https://orcid.org/0000-0002-9545-2709; Berthele, Achim
ORCID: https://orcid.org/0000-0001-9650-6222; Kirschke, Jan S.
ORCID: https://orcid.org/0000-0002-7557-0003 und Hemmer, Bernhard
ORCID: https://orcid.org/0000-0001-5985-6784
(2025):
Replication of the 2023 radiologically isolated syndrome criteria in a multi-centre cohort.
In: Brain Communications, Bd. 7, Nr. 5, fcaf323
[PDF, 858kB]
Abstract
Radiologically isolated syndrome (RIS) represents a pivotal stage for identifying individuals at high risk of transitioning into multiple sclerosis (MS). Early therapy initiation reduces the risk of conversion. The 2023-RIS criteria were proposed to identify presymptomatic individuals earlier. We aimed to replicate the diagnostic value of the 2023-RIS criteria in an independent cohort. In this retrospective cohort study, individuals diagnosed with RIS and longitudinally followed in three centres were stratified by the 2009- and 2023-RIS criteria. We conducted comparative analyses, including survival, hazard ratio and performance evaluations. Among n = 136 individuals, 27.2% converted to MS between 2009 and 2024 (observation time 55.4 months). We confirmed improved identification of individuals at risk using the 2023-RIS criteria (HR 4.30, P < 0.05; HR 4.71, P < 0.05) compared to 2009-RIS criteria (HR 1.32, P = 0.4; HR 1.43; P = 0.3) in 5- and 10-year intervals, respectively. 2023-RIS criteria demonstrated high sensitivity (94%) and negative predictive value (94%) but low specificity (29%). Adding CSF immunoglobulin G and M indices as an additional parameter following RIS diagnosis enhanced risk prediction specificity. We confirm the high sensitivity and predictive value of the 2023-RIS criteria for identifying individuals at risk of conversion to MS and suggest adding immunoglobulin indices to further improve specificity.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin > Munich Cluster for Systems Neurology (SyNergy) |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| URN: | urn:nbn:de:bvb:19-epub-129798-5 |
| Sprache: | Englisch |
| Dokumenten ID: | 129798 |
| Datum der Veröffentlichung auf Open Access LMU: | 26. Nov. 2025 07:39 |
| Letzte Änderungen: | 26. Nov. 2025 07:39 |
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 390857198 |
